Rutland, MA, United States of America

Anca Clabbers

USPTO Granted Patents = 8 

Average Co-Inventor Count = 10.4

ph-index = 4

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
8 patents (USPTO):

Title: The Innovative Contributions of Anca Clabbers in Biotherapeutics

Introduction: Anca Clabbers, an accomplished inventor based in Rutland, MA, has made significant advancements in the field of biotherapeutics. With a total of eight patents to her name, she has actively contributed to the development of groundbreaking solutions in medicine, particularly in the realm of binding proteins and antibodies.

Latest Patents: Among her latest innovations, Anca Clabbers has developed critical patents that include antibodies against platelet-derived growth factor (PDGF). These patents detail binding proteins capable of binding to one or more of vascular endothelial growth factor (VEGF), PDGF, and their receptors. The innovations encompass various forms of antibodies, such as CDR-grafted antibodies, humanized antibodies, binding fragments, fusion proteins, and multispecific proteins, alongside methods for their production and application. Another notable patent involves immunobinders directed against tumor necrosis factor-alpha (TNF-α), which consists of isolated binding proteins that target TNF-α, including human TNF-α. This work also highlights related antibody-based compositions and includes pharmaceutical formulations and diagnostic methods aimed at medical treatment.

Career Highlights: Anca Clabbers works at AbbVie Inc., a leading biopharmaceutical company known for its focus on developing solutions for some of the world’s most serious health challenges. Her inventive work has greatly contributed to AbbVie's portfolio in innovative drug development, particularly in treating conditions related to oncology and autoimmune diseases.

Collaborations: Collaboration is key in the field of biotherapeutics, and Anca has worked alongside prominent colleagues, including Chung-Ming Hsieh and Yuliya Kutskova. Together, they have collectively pursued research that pushes the boundaries of medical science and improves patient outcomes.

Conclusion: Anca Clabbers has established herself as a reputable inventor in the biotherapeutics industry, with a notable number of patents that signify her commitment to innovation. Her work not only advances scientific knowledge but also has the potential to impact the lives of many through improved therapeutic options. The pioneering efforts of inventors like Anca Clabbers continue to inspire future generations in the pursuit of medical breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…